Cargando…
2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors
Inhibition of the glycolytic pathway is a critical strategy in anticancer therapy because of the role of aerobic glycolysis in cancer cells. The glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) has shown potential in combination with other anticancer agents. Buforin IIb is an effective antimicrobial pe...
Autores principales: | Wanyan, Yangke, Xu, Xixi, Liu, Kehang, Zhang, Huidan, Zhen, Junai, Zhang, Rong, Wen, Jumei, Liu, Ping, Chen, Yuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730206/ https://www.ncbi.nlm.nih.gov/pubmed/33297583 http://dx.doi.org/10.3390/molecules25235778 |
Ejemplares similares
-
Cathelicidin hCAP18/LL-37 promotes cell proliferation and suppresses antitumor activity of 1,25(OH)(2)D(3) in hepatocellular carcinoma
por: Zhang, Huidan, et al.
Publicado: (2022) -
Buforin IIb induced cell cycle arrest in liver cancer
por: Li, Dan, et al.
Publicado: (2019) -
Effect of Hydrophobicity on the Anticancer Activity
of Fatty-Acyl-Conjugated CM4 in Breast Cancer Cells
por: Yang, Yunqing, et al.
Publicado: (2020) -
Novel peptide myristoly-CM4 induces selective cytotoxicity in leukemia K562/MDR and Jurkat cells by necrosis and/or apoptosis pathway
por: Zhang, Huidan, et al.
Publicado: (2019) -
Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model
por: Zhang, Huidan, et al.
Publicado: (2023)